Rise Therapeutics Revenue and Competitors

Location

$0.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Rise Therapeutics's total funding is $0.4M.

Employee Data

  • Rise Therapeutics has 17 Employees.(i)
  • Rise Therapeutics grew their employee count by 6% last year.

Rise Therapeutics's People

NameTitleEmail/Phone
1
Founder, President & CEOReveal Email/Phone
2
VP, Development and ManufacturingReveal Email/Phone
3
Clinical ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M20%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$9.6M62-15%N/AN/A
#6
$1.4M90%N/AN/A
#7
$2.5M130%N/AN/A
#8
$7.4M4721%N/AN/A
#9
$0.2M1-83%N/AN/A
#10
$1.7M1122%N/AN/A
Add Company

What Is Rise Therapeutics?

Rise Therapeutics is developing targeted immunological-based biologics using a unique and proprietary oral delivery platform. The company develops unique, first-in-class immune modulatory drugs for the treatment of inflammation, autoimmunity and cancer.

keywords:N/A

$0.4M

Total Funding

17

Number of Employees

N/A

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M176%N/A
#2
$1.5M17-6%N/A
#3
$4M17-6%N/A
#4
$1.5M17N/AN/A
#5
$15M1838%N/A